STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Blum Holdings Inc. Reports Remarkable 2024 Financial Results with $33.1 Million in Net Income

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Blum Holdings (OTCQB: BLMH) reported strong financial results for FY2024, achieving a remarkable turnaround with $33.1 million in net income, compared to losses of $14.1 million in 2023 and $188.7 million in 2022.

Key financial highlights include:

  • Revenue growth of 67% to $13.0 million
  • Gross profit increase of 63% to $6.2 million with 48% margin
  • EBITDA from continuing operations of $21.2 million
  • Liability reduction of 62% to $29.6 million
  • Earnings per share of $1.79 (basic) and $1.21 (diluted)

The California-based cannabis operator's performance was driven by successful integration of three Northern California retail stores contributing $7.7 million in revenue, strategic divestment of non-core dispensaries, and effective restructuring initiatives. The company completed its transformation with only $1.97 million in new capital raised, positioning itself for measured expansion and financial sustainability.

Loading...
Loading translation...

Positive

  • Net income turnaround to $33.1M from previous losses
  • 67% revenue growth to $13.0M year-over-year
  • 63% increase in gross profit to $6.2M with 48% margin
  • 62% reduction in liabilities to $29.6M
  • Positive EBITDA of $21.2M from continuing operations
  • Successful integration of profitable Northern California retail stores
  • Achieved transformation with minimal capital raise ($1.97M)

Negative

  • Adjusted EBITDA still showing losses of $10.9M despite improvement
  • Revenue growth partially offset by divestment of dispensaries
  • Diluted EPS lower than basic EPS indicating potential share dilution

News Market Reaction 1 Alert

+17.33% News Effect

On the day this news was published, BLMH gained 17.33%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DOWNEY, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced its financial results for the year ended December 31, 2024, marking the completion of a significant financial and operational transformation.

Key Highlights from Fiscal Year 2024:

  • Net Income: $33.1 million, representing an astonishing turnaround from a net loss of $14.1 million in 2023 and a net loss of $188.7 million in 2022, reflecting the successful restructuring and cost optimization efforts.

  • Liability Reduction: Decreased by 62% to $29.6 million in 2024, from $77.8 million in 2023 and $125.3 million at the beginning of 2022, reflecting effective balance sheet management and successful restructuring strategies implemented during the tenure of the Adnant engagement.

  • Earnings per Share:

    • Basic: $1.79 in 2024, compared to a loss per share of $1.67 in 2023.

    • Diluted: $1.21 in 2024, compared to a loss per share of $1.67 in 2023.

  • Revenue Growth: Increased by 67% year-over-year to $13.0 million, an increase from $7.8 million in 2023, primarily driven by the successful integration of three Northern California retail stores, which contributed $7.7 million to revenue, partially offset by the strategic divestment of non-core dispensaries.

  • Gross Profit: Increased by 63% to $6.2 million, up from $3.8 million in 2023, with a gross margin of 48%, reflecting strong operational execution despite a competitive pricing environment.

  • EBITDA from Continuing Operations: $21.2 million, a $31.6 million improvement from an EBITDA loss of $10.4 million in 2023, highlighting enhanced operational efficiency and profitability.

  • Adjusted EBITDA from Continuing Operations: A loss of $10.9 million, a notable improvement from $16.8 million in 2023, underscoring management’s focus on financial performance.

Patty Chan, Chief Financial Officer of Blüm Holdings, commented: "Blüm’s 2024 performance is a testament to the disciplined execution of our financial, restructuring, litigation, and operational strategies. By strategically divesting underperforming assets, deconsolidating Unrivaled Brands and Halladay Holding, and integrating key retail locations, we have significantly streamlined our operations. These foundational improvements have strengthened our financial position, enabling us to enter 2025 as a more agile, efficient, and financially stable organization. With this momentum, we remain committed to disciplined capital allocation and strategic acquisitions that align with our long-term vision for sustainable growth and value creation."

Sabas Carrillo, Chief Executive Officer of Blüm Holdings, added: "Over the past two years, we executed one of the most aggressive financial restructurings in the cannabis sector, transforming Blüm into a leaner, stronger, and more resilient company. We have positioned ourselves to capitalize on value-accretive opportunities that will drive shareholder returns and long-term success. It is important to note that we achieved these extraordinary results with only $1.97 million in new capital raised during this period. This underscores the strength of our execution and financial discipline.

With our restructuring and reorganization completed, litigation resolved, and a more streamlined operational model, Blüm has transitioned from a defensive restructuring phase to a strategy focused on measured expansion and financial sustainability. We are actively evaluating opportunities in retail, cultivation, and distribution that align with our hybrid approach—balancing vertical integration with a multi-brand retail platform. As we look ahead, together with the recently raised capital, we are well-positioned to pursue strategic growth initiatives that strengthen our platform, expand our market presence, and reinforce our commitment to long-term shareholder value."

About Blüm Holdings

Blüm Holdings is a leader in the cannabis sector. Our commitment to quality, innovation, and customer service makes us a trusted name in the cannabis industry, dedicated to shaping its future. Blüm Holdings, through its subsidiaries, operates leading dispensaries throughout California as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories, including the legendary 1000 mg THC Black Bar. As both a holding company and a marketing platform, Blüm aims to leverage its growing ecosystem to accelerate customer and retail investor acquisition, increase brand awareness, and create value across its portfolio.

For more info, please visit: https://blumholdings.com.
Follow us on Instagram @blumholdings

Contact:
Jason Assad
LR Advisors LLC.
jassad@blumholdings.com
678-570-6791

Non-GAAP Financial Information

This press release includes certain non-GAAP financial measures as defined by the U.S. Securities and Exchange Commission (the “SEC”). Management believes that these non-GAAP financial measures assess the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. These non-GAAP financial measures exclude certain material non-cash items and certain other adjustments the Company believes are not reflective of its ongoing operations and performance. Management uses non-GAAP financial measures, in addition to GAAP financial measures, to understand operational decision-making, for planning and forecasting purposes, and to evaluate the Company’s financial performance. Management believes that these non-GAAP financial measures enhance investors’ understanding of the Company’s financial and operating performance and enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with GAAP are included in the financial schedules attached to this press release. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.

Cautionary Language Concerning Forward-Looking Statements

Certain statements contained in this communication regarding matters that are not historical facts, are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include statements regarding management's intentions, plans, beliefs, expectations, or forecasts for the future, and, therefore, you are cautioned not to place undue reliance on them. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by law. The Company uses words such as “anticipates,” “believes,” “plans,” “expects,” “projects,” “future,” “intends,” “may,” “will,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “guidance,” and similar expressions to identify these forward-looking statements that are intended to be covered by the safe-harbor provisions of the PSLRA. Such forward-looking statements are based on the Company’s expectations and involve risks and uncertainties; consequently, actual results may differ materially from those expressed or implied in the statements due to a number of factors.

New factors emerge from time-to-time and it is not possible for the Company to predict all such factors, nor can the Company assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. These risks, as well as other risks associated with the combination, will be more fully discussed in the Company’s reports with the SEC. Additional risks and uncertainties are identified and discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed from time to time with the SEC. Forward-looking statements included in this release are based on information available to the Company as of the date of this release. The Company undertakes no obligation to update such forward-looking statements to reflect events or circumstances after the date of this release.

     
     
  (in thousands)
  December 31, December 31,
   2024   2023 
Current Assets $2,871  $4,693 
Long-Term Assets  21,949   27,378 
Total Assets $ 24,820  $ 32,071 
     
Current Liabilities $9,659  $62,548 
Long-Term Liabilities  19,905   15,219 
Total Liabilities  29,564   77,767 
     
Mezzanine Equity and Stockholders' Deficit  (4,744)  (45,696)
     
Total Liabilities, Mezzanine Equity and Stockholders' Deficit $ 24,820  $ 32,071 
     


     
  (in thousands)
  Year Ended
  December 31, December 31,
   2024   2023 
Revenue $12,990  $7,756 
Cost of Goods Sold  6,782   3,948 
Gross Profit $ 6,208  $ 3,808 
Gross Profit %  48%   49% 
     
Operating Expenses  826   22,609 
Income (Loss) from Operations  5,382   (18,801)
     
Less: Other Income  (12,928)  (5,691)
Income (Loss) from Continuing Operations Before Taxes  18,310   (13,110)
     
Provision for Income Tax Expense for Continuing Operations  (1,417)  (576)
Net Income (Loss) from Continuing Operations $ 16,893  $ (13,686)
     
Net Income (Loss) from Discontinued Operations, Net of Tax  16,205   (444)
Net Income (Loss) $ 33,098  $ (14,130)
     
Basic and Diluted Loss per Share:    
Net Income (Loss) from Continuing Operations per Common Share - Basic $1.79  $(1.67)
Net Income (Loss) from Continuing Operations per Common Share - Diluted $1.21  $(1.67)
     


     
  (in thousands)
  Year Ended
  December 31, December 31,
  2024
 2023
Net Income (Loss) $33,098  $(14,130)
Less: Net Income (Loss) from Discontinued Operations, Net  (16,205)  444 
Add Impact of:    
Interest Expense  2,123   2,417 
Provision for Income Tax Expense  1,417   576 
Depreciation Expense  584   327 
Amortization of Intangible Assets  148   - 
EBITDA Income (Loss) from Continuing Operations (Non-GAAP) $21,165  $(10,366)
     
Non-GAAP Adjustments:    
Stock-based Compensation Expense  371   2,435 
Impairment of Assets  1,709   - 
Severance Expense  61   - 
Realized (Gain) Loss on Sale of Investments  (167)  61 
Unrealized Gain on Investments  -   (667)
(Gain) Loss on Disposal of Assets  (19,439)  1,607 
Gain on Settlement of Liabilities  -   (4,434)
Change in Fair Value of Derivative Liability  492   - 
Gain on Extinguishment of Debt  (15,133)  (5,441)
Adjusted EBITDA Loss from Continuing Operations (Non-GAAP) $(10,941) $(16,805)
     

FAQ

What was Blum Holdings (BLMH) net income for fiscal year 2024?

Blum Holdings reported a net income of $33.1 million for FY2024, a significant turnaround from losses of $14.1 million in 2023.

How much did BLMH reduce its liabilities in 2024?

BLMH reduced liabilities by 62%, from $77.8 million in 2023 to $29.6 million in 2024.

What was BLMH's revenue growth and main driver in 2024?

Revenue grew 67% to $13.0 million, primarily driven by three Northern California retail stores contributing $7.7 million.

What were BLMH's earnings per share for 2024?

BLMH reported basic EPS of $1.79 and diluted EPS of $1.21 for 2024, compared to a loss of $1.67 per share in 2023.

How much did BLMH's EBITDA improve in 2024?

EBITDA from continuing operations reached $21.2 million, a $31.6 million improvement from a $10.4 million loss in 2023.
Blum Holdings

OTC:BLMH

BLMH Rankings

BLMH Latest News

BLMH Latest SEC Filings

BLMH Stock Data

8.67M
20.61M
34.77%
Pharmaceutical Retailers
Healthcare
Link
United States
Downey